TAKEDA-SYR-322_402

Study Sponsor : Takeda

Study Title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome

Medicine or Vaccine (generic name)

alogliptin

Sponsor Identification Number

SYR-322_402

Trial Registry Identification Number(#'s)

NCT00968708
2009-011222-34

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to study details on the Takeda Clinical Study Register

http://takedaclinicaltrials.com/browse/summary/SYR-322_402

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/ct2/show/NCT00968708?term=SYR-322_402&rank=1

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011222-34/BE

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2015